Halaman 3 - Konsultasi Daring dengan Dokter Onkologi Dokter Terbaik - TOP-114 dokter

Dr. Balaña received her medical degree from the Central University of Barcelona and completed her residency in medical oncology at one of the best public hospitals in Spain, Vall d'Hebrón Hospital.

She was a leading specialist in the treatment of brain tumors at the Institute of Oncology of Catalonia, a founding member and current president of the Spanish Neuro oncology Research Group (GEINO), and a member of the scientific committee of the European Association for Neuro-Oncology.

He is the recipient of prestigious research grants in the field of brain tumors.

Dr. Balaña is also a member of the European Society of Medical Oncology and the author of modern European protocols for the treatment of brain tumors, as well as the protocols of the Spanish Society of Medical Oncology (SEOM).

Dr. Balaña has published over 400 articles, books and scientific papers at national and international conferences.

He is the author of articles in prestigious scientific publications such as:

Lancet Oncology;

Nature Reviews in Clinical Oncology;

Clinical Cancer Research and others.

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

Dokter adalah ahli bedah onkologi yang mengkhususkan diri dalam karsinomatosis peritoneal dan merupakan bagian dari Grup Bedah Karsinomatosis Institut Onkologi Teknon sejak 2019. Dia menyelesaikan spesialisasinya di Washington Hospital Center di bawah Prof. Paul Sugarbaker dan memiliki sertifikasi American Board of Surgery.<\/p>

Dia adalah anggota dari beberapa masyarakat bergengsi, termasuk American College of Surgeons dan Society of Surgical Oncology. Peran akademisnya termasuk Direktur Penelitian di Inova Fairfax Hospital dan posisi Profesor Madya di Virginia Commonwealth University dan Georgetown University.<\/p>

Dokter lulus dari Fakultas Kedokteran Universitas Ankara dan menyelesaikan pelatihan residensi dalam bidang penyakit dalam di Fakultas Kedokteran GATA Ankara. Mengkhususkan diri dalam onkologi medis dan hematologi, dokter menyelesaikan fellowship klinis di AS. Sebagai pelopor di Turki, dokter adalah bagian dari tim yang melakukan transplantasi sumsum tulang pertama di negara tersebut. Dokter telah menjadi dosen tamu di lembaga-lembaga bergengsi di London dan Swiss. Memegang Sertifikat Onkologi Medis Eropa, dokter adalah anggota pendiri dari baik Masyarakat Onkologi Medis Turki maupun Kelompok Onkologi Turki. Fokus klinis termasuk kanker payudara, gastrointestinal, paru-paru, limfoma, dan mieloma.<\/p>

Prof. Dr. Sezer Sağlam is a medical oncologist at Gayrettepe Florence Nightingale Hospital. He specializes in gastrointestinal and breast cancers. He has contributed to cancer care through research, especially with his study on the best timing for surgery after neoadjuvant therapy in rectal cancer. This work has influenced global treatment protocols.

Dr. Sağlam has led clinical trials in targeted therapies and precision medicine. His research on liver-transplanted patients with hepatocellular carcinoma was nominated for the 2024 International Best Researcher Award. He is a member of ASCO, ESMO, and ENET. Dr. Sağlam provides personalized and evidence-based oncology care.

Dokter adalah tokoh terkemuka dalam onkologi medis, hematologi, dan imunoterapi kanker, dengan karier yang mencakup lebih dari empat dekade. Setelah meraih gelar kedokteran dari Universitas Wina pada tahun 1970-an, dokter menyelesaikan pelatihan spesialisasi dalam bidang penyakit dalam dan onkologi pada tahun 1980-an.<\/p>

Pada tahun 1990-an, dokter diangkat sebagai Kepala Divisi Klinis Onkologi di Universitas Kedokteran Wina, memimpin departemen onkologi terbesar di Austria. Tahun 2000-an menyaksikan pendirian Pusat Kanker Komprehensif Wina, yang mengintegrasikan perawatan pasien, penelitian, dan pendidikan.<\/p>

Dokter menjabat sebagai Presiden Kelompok Onkologi Kooperatif Eropa Tengah pada tahun 2010-an dan saat ini memegang posisi sebagai Ketua Pusat Kanker Wina dan Direktur Medis Pusat Onkologi Internasional Wiener Privatklinik.<\/p>

Dokter lulus dari Universitas Grodno, Belarus, dan memperoleh lisensi medis di Israel pada tahun 2000. Mengkhususkan diri dalam bidang penyakit dalam dan onkologi, dokter menyelesaikan magang di Departemen Penyakit Dalam ke-10 dan Onkologi di Pusat Medis Tel Aviv, Ichilov. Sejak 2015, dokter telah menjabat sebagai direktur rawat inap onkologi di pusat yang sama.<\/p>

Dengan pengalaman luas sebagai peneliti utama dan sekunder, dokter telah berpartisipasi dalam studi klinis fase pertama, kedua, dan ketiga dalam onkologi, memberikan kontribusi yang signifikan di bidang ini.<\/p>

Dokter adalah spesialis berpengalaman dalam Transplantasi Sumsum Tulang, setelah lulus dari Sekolah Kedokteran Universitas Ibrani pada tahun 1999. Setelah itu, dokter mengambil spesialisasi dalam bidang penyakit dalam di Pusat Medis Hadassah. Dokter kemudian bergabung dengan departemen Transplantasi Sumsum Tulang di Hadassah sebagai dokter senior, memberikan kontribusi keahlian yang signifikan di bidang ini.<\/p>

Kodchanut Litleaungdej, M.D.

Dokter adalah pakar terkemuka dalam hematologi dan onkologi pediatrik, yang mengkhususkan diri dalam gangguan darah dan kanker tulang (sarkoma) pada anak-anak. Saat ini, dokter menjabat sebagai direktur departemen hematologi onkologi anak di Sourasky Medical Center di Tel Aviv dan merupakan dokter anak senior di Rumah Sakit Anak Dana. Dokter mengoordinasikan perawatan untuk kanker tulang dan sarkoma jaringan lunak, mengelola gangguan pembekuan darah, dan mengawasi hematologi pada bayi prematur. Dokter adalah anggota Asosiasi Hemato-Onkologi Pediatrik Israel (ISPHO).

Dokter lulus dari Universitas Ben-Gurion dan mengkhususkan diri dalam kedokteran anak di Kaplan Medical Center, dengan spesialisasi lebih lanjut dalam hematologi dan onkologi pediatrik di Schneider Children's Medical Center. Pelatihan tambahan diselesaikan dalam onkologi tulang dan jaringan lunak di Institut Ortopedi Rizzoli di Italia.

Dokter adalah spesialis terkemuka di departemen terapi nuklir di Klinik Ichilov, berfokus pada perawatan inovatif untuk tumor neuroendokrin menggunakan terapi radionuklida dengan Lutetium-177. Metode ini, tersedia di Israel, Jerman, dan Swedia, secara selektif menghancurkan sel kanker sambil menyelamatkan jaringan sehat, menghindari efek samping parah dari kemoterapi tradisional.<\/p>

Dengan gelar medis dari Vitebsk, Belarus, dan spesialisasi dalam onkologi dan terapi radiasi dari Rumah Sakit Universitas Hadassah, dokter memiliki pengalaman luas dalam onkologi, terutama dalam terapi radiasi untuk anak-anak, tumor gastrointestinal, kepala, leher, dan kulit.<\/p>

Associate Professor Dr. Yusuf AÇIKGÖZ
Specialization: Medical Oncology

Education:

• 2004-2011: İnönü University Faculty of Medicine
• 2011-2016: Ankara Numune Training and Research Hospital, Internal Medicine
• 2017-2022: Health Sciences University, Medical Oncology

Professional Experience:

• 2016-2017: Bingöl City Hospital, Internal Medicine
• 2021-2022: Health Sciences University, Medical Oncology
• 2022-2023: Kastamonu Education and Research Hospital, Medical Oncology
• 2023-2024: Ohio State University, Medical Oncology
• 2024-Present: Lokman Hekim University, Medical Oncology, Ankara Hospital

Clinical Trials, Courses, Certifications:

Clinical Trials:

• 2017-2021: Phase III, CheckMate-649 Study (Assistant Investigator)
• 2022-Present: Phase III, Fortitude-101 Study (Assistant Investigator)

Courses:

• 2018: Medicres Basic and Advanced Biostatistics Training Program (ongoing), Istanbul-Vienna
• 2019: Immuno-Oncology Education Course, March 1-2, 2019, Vienna, Central European Cooperative Oncology Group (CECOG)
• 2018: Good Clinical Practice Certification, April 7-8, 2018, Ankara, Health Sciences University
• 2017: Basic Oncology Training Program, November 25-26, 2017, Adana, Clinical Oncology Society
• 2016: Basic Ultrasonography Course (10 hours theoretical + 10 hours practical), September 24-25, 2016, Ankara, Turkish Emergency Medicine Association

Certifications:

• Ongoing: ECFMG Certification
• 2024: CITI Responsible Conduct of Research (The Ohio State University)
• 2024: CITI IACUC-Laboratory Animal Research (The Ohio State University)
• 2024: CITI Human Subjects Protection (The Ohio State University)
• 2024: CITI Good Clinical Practice (The Ohio State University)
• 2023: Occupational English Test (OET)
• 2019: International English Language Testing System (IELTS), Total Score: 6.5, May 26, 2019, Ankara, British Council
• 2017: USMLE Step 2 CK Exam; Score: 244, February 7, 2017
• 2016: USMLE Step 1 Exam; Score: 215, August 25, 2016

Memberships:

• American Society of Clinical Oncology (ASCO) - 2022
• Turkish Society of Medical Oncology - 2020

Dokter adalah seorang ahli onkologi yang berspesialisasi dalam pengobatan kanker payudara, paru-paru, dan saluran pencernaan. Saat ini, dokter berpraktik di Rumah Sakit Universitas Istinye Liv.

Dengan karier yang mencakup berbagai institusi terkemuka, dokter telah bertugas sebagai Spesialis Penyakit Dalam di Rumah Sakit Negara Malatya, dokter di Klinik Onkologi Ankara, dan anggota Departemen Onkologi di Rumah Sakit Pelatihan dan Penelitian Regional Erzurum.

Dokter lulus dari Fakultas Kedokteran Universitas Selcuk dan meraih gelar Associate Professor pada tahun 2016.

Education & Expertise

• 1998 to 2004 – Istanbul University, Istanbul Faculty of Medicine
• 2005 to 2009 – Düzce University, Internal Medicine Specialization
• 2009 to 2010 – Beytüşşebap State Hospital, Compulsory Internal Medicine Service
• 2010 to 2013 – Bülent Ecevit University, Medical Oncology Specialization
• 2013 to 2015 – Recep Tayyip Erdoğan University, Medical Oncology Compulsory Service
• 2015 to Present – Associate Professor, Recep Tayyip Erdoğan University
• 2015 to 2021 – Lecturer, Medical Oncology, Sakarya University Faculty of Medicine
• 2020 to Present – Professor, Sakarya University Faculty of Medicine
• 2020 to Present – Ph.D. Student, Inorganic Chemistry, Sakarya University

Experience

• 2008 – Cleveland Clinic, Rheumatology & Gastroenterology Rotation
• 2016 to 2017 – Northeastern University, The Center for Pharmaceutical Biotechnology and Nanomedicine, Boston, U.S.

Professional Memberships

• TTOD (Turkish Society of Medical Oncology)
• ASCO (American Society of Clinical Oncology)
• ESMO (European Society for Medical Oncology)

Education and Specialization

• 2006: Kocaeli University Faculty of Medicine
• 2014: Akdeniz University Faculty of Medicine, Internal Medicine
• 2018: Akdeniz University Faculty of Medicine, Medical Oncology

Experience

• 2006 - 2008: Konya Derebucak District Hospital
• 2009 - 2015: Akdeniz University Hospital
• 2015: Antalya Kaş State Hospital
• 2015 - 2016: İnönü University Faculty of Medicine
• 2016 - 2021: Akdeniz University Hospital
• 2021 - 2023: Antalya Training and Research Hospital

Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.

He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.

His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).